We are live on
!
Find out more
SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
0 hedge funds and large institutions have $0 invested in scPharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 108 closing their positions.
New
Increased
Maintained
Reduced
Closed
76.85% less ownership
Funds ownership: 76.85% → 0% (-77%)
100% less funds holding
Funds holding: 109 → 0 (-109)
100% less capital invested
Capital invested by funds: $232M → $0 (-$232M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 108
Holders
–
Holders Change
-109
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
108
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
O
OrbiMed
New York
|
-$34.4M |
| 2 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$28.9M |
| 3 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
-$16.3M |
| 4 |
BlackRock
New York
|
-$13.5M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$12.3M |
